Effect of oral curcumin on the size, pain and burning sensation of oral lichen planus lesions

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201607032950N4

Enrollment

Registered

2016-10-29

Start date

2016-07-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral lichen planus. Lichen planus

Interventions

Consumption 80 mg oral curcumin capsule once a day for 1 month.

Treatment - Drugs

Consumption 80 mg oral curcumin capsule once a day for 1 month

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with oral lichen planus(confirmed by clinical examination, biopsy and histopathological evaluation) exclusion criteria: pregnant woman, breast feeding woman, patients who take corticosteroid, patients with peptic ulcer, gall-bladder stone, increased hepatic enzyme, and patients who take anti coagulation drug, like warfarin.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain and burning sensation. Timepoint: before using drug and 1,2,4,8 after using drug. Method of measurement: use of visual analogue scale(VAS).	—

Secondary

Measure	Time frame
Size of the lichen planus lesions. Timepoint: Before treatment and 1,2,4,8 week after treatment. Method of measurement: tongprasom scale(0-5).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Seyed Javad Kia

Dental school of guilan university of medical science

djavadkia@yahoo.com+98 13 3323 7877

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026